Dermatofibrosarcoma is a common, but unusual locally aggressive cutaneous tumor. Its characteristic tentacle can grow into surrounding fat, muscle and even bone. For dermatologists this means that understanding treatment options is a priority, says a physician reporting from EADV 2018.
Is it just a “spot” or precancerous lesion? Two physicians debate how best to treat actinic keratosis in a talk given at EADV last week.
There are many non-surgical treatments for basal cell carcinomas, but a physician reporting at EADV last week said new treatments should be compared against surgery, which has the highest cure rate and lowest rate of recurrence.
A pregnancy-associated melanoma (PAM) prognosis does not appear to be worse than melanoma in non-pregnant controls, researchers reported at EADV. Nonetheless, measures should be taken to protect the fetus in the treatment and imaging of PAM.
EADV report summarizes the latest advances in laser technology for tattoo removal.
Life-threatening emergency cases may be rare, but they can be complex. At EADV this week, experts review cases physicians should be aware of.
A study presented at EADV in Paris today showed that dupilumab met its primary endpoints in a phase three study of adolescents with moderate-to-severe atopic dermatitis.
EADV report shows that two JAK inhibitors reverses alopecia areata in some patients.
Potential new treatment with targeted monoclonal antibodies offers new hope for cutaneous lymphoma patients.
Clinicians are more likely to correctly identify the lesions’ underlying cause with careful observation rather than with several lab tests.